MORF,Morphic Holding, Inc. | Healthcare

Healthcare

MORF

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

Morphic Holding, Inc.MORF

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, and metabolic diseases, as well as fibrosis and cancer.

Its lead product candidate MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation is in Phase 2 clinical trials for the treatment of inflammatory bowel disease.

The company's products in pipeline include Next Gen a4ß7 Inhibitors for additional potential GI indications, such as EGIDs, pouchitis, etc.; avß8 for the treatment of Myelofibrosis and solid tumor; and fibronectin integrin for pulmonary hypertensive.

In addition, it has a license agreement with Janssen to discover and develop novel integrin therapeutics; collaboration agreement with Schrödinger for integrin targets; and license agreement with Children's Medical Center Corporation to develop and commercialize products worldwide for any therapeutic or diagnostic use in humans and veterinary applications.

The company was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

Latest News >

Caturus' Wellhead-to-Water Strategy Achieves Major Milestones in Upstream and LNG Development

Apr 7, 2026

Commonwealth LNG Project achieves full commerciality Project financing process imminent for $12.5 billion LNG project Pre-FID site objectives progressing with EPC partner Technip Energies Pending $950 million acquisition of SM Energy assets remains on track HOUSTON, April 7, 2026 /PRNewswire/ -- Caturus announced today its Commonwealth LNG project has finalized customer offtake agreements to underpin financing of its LNG facility in...

Booz Allen Completes Acquisition of Defy Security

Apr 7, 2026

Accelerating Advanced Cybersecurity for New Age of Enterprise Threats MCLEAN, Va.--(BUSINESS WIRE)-- Booz Allen Hamilton ( BAH ) today announced it has completed its acquisition of Defy Security. The transaction was previously announced on February 17, 2026. Defy provides cybersecurity technology products and services to leading financial services, healthcare, manufacturing, and retail enterprises. Combining its robust customer base, sales infrastructure,...

North American Construction Group Closes Strategic Acquisition of Iron Mine Contracting, a Diversified Mining Services Contractor

Apr 7, 2026

ACHESON, Alberta, April 07, 2026 (GLOBE NEWSWIRE) -- North American Construction Group Ltd. ( NOA ) (“NACG” or the “Company”) today announced the closing of its acquisition of Iron Mine Contracting (“IMC”), with a closing date of April 7, 2026 and an economic effective date of January 1, 2026 (the “Transaction”). Total expected consideration is approximately $125 million (the “Consideration”),...

Wealthspire’s Fiducient Advisors Acquires Axia Advisory

Apr 7, 2026

$1.9 billion retirement plan consultant in Indianapolis joins growing national platform NEW YORK--(BUSINESS WIRE)-- Wealthspire, an independent wealth management, institutional advisory, and business management firm, today announced that Fiducient Advisors has completed its acquisition of Axia Advisory, an Indianapolis-based retirement plan consulting and investment advisory firm with $1.9 billion in assets under management or advisement.* The addition of Axia...